False-positive extended-spectrum β-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 β-lactamase

被引：35

作者：

Potz, NAC

Colman, M

Warner, M

Reynolds, R

Livermore, DM

机构：

[1] Hlth Protect Agcy, Specialist & Reference Microbiol Div, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England

[2] British Soc Antimicrobial Chemotherapy, Birmingham B1 2JS, W Midlands, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2004年 / 53卷 / 03期

关键词：

interpretation of ESBL test results; ceftazidime; cefotaxime; cefepime; cefpodoxime;

D O I：

10.1093/jac/dkh112

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：545 / 547

页数：4

相关论文

共 6 条

[1] Andrews J, 2003, E COLI KLEBSIELLA SP
[2] Determination of minimum inhibitory concentrations
Andrews, JM
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 : 5 - 16
[3] Detection of β-lactamase-mediated resistance
Livermore, DM
Brown, DFJ
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 : 59 - 64
[4] Detection of extended spectrum β-lactamases in the routine clinical microbiology laboratory
Midolo, PD
Matthews, D
Fernandez, CD
Kerr, IG
[J]. PATHOLOGY, 2002, 34 (04) : 362 - 364
[5] Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates
Stürenburg, E
Sobottka, I
Feucht, HH
Mack, D
Laufs, R
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 45 (01) : 29 - 34
[6] Controversies about extended-spectrum and AmpC beta-lactamases
Thomson, KS
[J]. EMERGING INFECTIOUS DISEASES, 2001, 7 (02) : 333 - 336